SINTBILO
Live / Registered — Registered (as of 21 Sept 2021)
What this means for you
Registered since 21 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90160130
- Registration number
- 6489680
- Mark type
- Word mark
- Filed
- 04 Sept 2020
- Published for opposition
- 06 Jul 2021
- Registered
- 21 Sept 2021
- Attorney of record
- Anessa Owen Kramer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer and antivirals; diagnostic preparations for medical purposes
Owner
- Innovent Biologics (Suzhou) Co., Ltd., Suzhou City, CN
- Innovent Biologics (Suzhou) Co., Ltd., Suzhou City, CN
- Innovent Biologics (Suzhou) Co., Ltd., Suzhou City, CN
Prosecution history
- 21 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jul 2021 — PUBLISHED FOR OPPOSITION
- 16 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jun 2021 — EXAMINER'S AMENDMENT ENTERED
- 01 Jun 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Jun 2021 — EXAMINERS AMENDMENT E-MAILED
- 01 Jun 2021 — EXAMINERS AMENDMENT -WRITTEN
- 26 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 May 2021 — ASSIGNED TO LIE
- 22 Feb 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jan 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Jan 2021 — NON-FINAL ACTION E-MAILED